Your browser doesn't support javascript.
loading
Emerging Approaches for Enabling RNAi Therapeutics.
Mallick, Argha M; Tripathi, Archana; Mishra, Sukumar; Mukherjee, Asmita; Dutta, Chiranjit; Chatterjee, Ananya; Sinha Roy, Rituparna.
Affiliation
  • Mallick AM; Department of Biological Sciences, Indian Institute of Science Education and Research Kolkata, Mohanpur, 741246, India.
  • Tripathi A; Department of Biological Sciences, Indian Institute of Science Education and Research Kolkata, Mohanpur, 741246, India.
  • Mishra S; Department of Biological Sciences, Indian Institute of Science Education and Research Kolkata, Mohanpur, 741246, India.
  • Mukherjee A; Department of Biological Sciences, Indian Institute of Science Education and Research Kolkata, Mohanpur, 741246, India.
  • Dutta C; Department of Chemical Sciences, Indian Institute of Science Education and Research Kolkata, Mohanpur, 741246, India.
  • Chatterjee A; Present address:Department of Biological Sciences, NUS Environmental Research Institute (NERI), National University of Singapore (NUS), Block S2 #05-01, 16 Science Drive 4, Singapore, 117558, Singapore.
  • Sinha Roy R; Department of Biological Sciences, Indian Institute of Science Education and Research Kolkata, Mohanpur, 741246, India.
Chem Asian J ; 17(16): e202200451, 2022 Aug 15.
Article in En | MEDLINE | ID: mdl-35689534
ABSTRACT
RNA interference (RNAi) is a primitive evolutionary mechanism developed to escape incorporation of foreign genetic material. siRNA has been instrumental in achieving the therapeutic potential of RNAi by theoretically silencing any gene of interest in a reversible and sequence-specific manner. Extrinsically administered siRNA generally needs a delivery vehicle to span across different physiological barriers and load into the RISC complex in the cytoplasm in its functional form to show its efficacy. This review discusses the designing principles and examples of different classes of delivery vehicles that have proved to be efficient in RNAi therapeutics. We also briefly discuss the role of RNAi therapeutics in genetic and rare diseases, epigenetic modifications, immunomodulation and combination modality to inch closer in creating a personalized therapy for metastatic cancer. At the end, we present, strategies and look into the opportunities to develop efficient delivery vehicles for RNAi which can be translated into clinics.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: RNAi Therapeutics / Neoplasms Limits: Humans Language: En Journal: Chem Asian J Year: 2022 Document type: Article Affiliation country: India

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: RNAi Therapeutics / Neoplasms Limits: Humans Language: En Journal: Chem Asian J Year: 2022 Document type: Article Affiliation country: India